Colorectal cancer is the third most common cancer in males and second in females. This disease can be caused by genetic and acquired/environmental factors. Microsatellite instability (MSI) is one of the major mechanisms in colorectal cancer. This mechanism is a specific condition of genetic hyper mutability that results from incompetent DNA mismatch repair. MSI has been applied to classify different colorectal cancer subtypes. However, the effects of MSI status on gene expression are largely unknown. In our study, we integrated the gene expression profile and MSI status of all CRC samples from the TCGA database, and then categorized the CRC samples into three subgroups, namely, MSI-stable, MSI-low, and MSI-high, according to the MSI status. We applied a novel computational method based on machine learning and screened the genes specifically expressed for the different colorectal cancer subtypes. The results showed the distinct mechanisms of the different colorectal cancer subtypes with MSI status and provided the genes that may be the optimal standards to further classify the various molecular subtypes of colorectal cancer with distinct MSI status.
Introduction
Cancer is a major cause of morbidity and mortality, with $14 million new cases and 8 million cancer-related deaths annually. 1 Among the cancer types, colorectal cancer is the third most common cancer in males and second in females, accounting for $774,000 deaths annually worldwide. 2 More than 65% of new cases have been recorded in countries with high or very high levels of human development. Approximately 50% of the estimated new cases are noted in Europe and America. In 2014, records in the US showed 139,992 new cases and 51,651 mortalities caused by colorectal cancer. 1 The probability of developing CRC is higher for men than for women and increases with age, especially after 50 years old. 1, 3, 4 Colorectal cancer can be developed because of genetic and acquired/environmental factors. The acquired/environmental factors encompass high intake of fat, alcohol, red meat, obesity, smoking, and lack of physical exercise 1 . The most prominent environmental factors have been proved to be lack of physical exercises and inflammatory bowel disease. 2 Approximately 10% of colorectal cancer cases are related to insufficient physical activity. 5 Hereditary colorectal cancer, Lynch syndrome, and familial adenomatous polyposis account for 20% of all cases of colorectal cancer. 6 At least three genetic mechanisms have been implicated in colorectal cancer, namely, chromosomal instability, microsatellite instability (MSI), and the CpG island methylator phenotype. In addition to the inherited variants, many somatic mutations in cancer-related genes, such as TP53, APC, and KRAS, have been detected in colorectal cancer. 7, 8 The precise diagnosis and treatment of patients with colorectal cancer remains challenging because of the genetic complexity and heterogeneity of this disease. MSI is a specific condition of genetic hyper mutability that results from incompetent DNA mismatch repair (MMR).
To date, seven proteins of the MMR system have been identified. These proteins are MSH2, MLH1, MLH3, MSH6, MSH3, PMS1, and PMS2. In early 1998, the MSI level has been associated with the formation and accumulation of the pathologic variants in xeroderma pigmentosum. This result revealed for the first time the potential pathogenic contributions of MSI. 9 The MSI pathway is involved in approximately 15% of sporadic colorectal cancers and >95% of hereditary non-polyposis colorectal cancer. This phenomenon suggests that identification of MSI has marked clinical implication for this malignancy. Furthermore, Keytruda (also known as pembrolizumab), as a novel anti-tumor drug, has only been recommended to treat patients with high MSI level or mismatch repair (MMR) deficiency because of its specific pharmacological functions. 10 Studies have indicated that colorectal cancer with different MSI levels may have distinct underlying mechanisms involving various genes. ZBTB2, RANBP2, and PSRC1 have been confirmed to be involved in MSIassociated carcinogenesis. This finding partially reveals the downstream pathological regulatory complexity of cases with different MSI statuses in colorectal cancer. 11 MSI has been also introduced to classify different colorectal cancer subtypes, and this practice further validates the unique effect of MSI status on classifying the contributions in the subtypes of colorectal cancer. 12 However, the underlying mechanism that determines the MSI status, such as the number and identity of genes that will be affected by MSI, remain ambiguous. Further, recent studies have also confirmed that colorectal cancer patients with different MSI status may have distinctive drug reactivity and sensitivity, implying that MSI status may also be a potential influential factor of clinical medication. 13, 14 With the development of next generation sequencing and medicine design techniques, the differential pharmacological effects of drugs on patients with different MSI status have been identified and taken into account during the drug design and clinical experiments phases. The identification of potential MSI effects on pharmacological processes can deepen our understanding on pharmacological mechanisms and promote the development of personalized precision medicine. Take Nivolumab as an example. Nivolumab, as a medication used to treat different cancer subtypes including melanoma, lung cancer and renal carcinoma, has been reported to have different pesticide effects on colorectal cancer subtypes with different MSI status, 15 involving distinctive pharmacological mechanisms. Therefore, the identification and recognition of MSI associated genes and their respective biological functions may also contribute to the revelation of potential pharmacological mechanisms and their different pharmacological effect on different colorectal cancer subtypes, laying a theoretical foundation for further clinical medication guidance.
In our study, we summarized two datasets of gene expression profile and MSI status of all CRC samples from the TCGA database. According to the MSI status of each sample, we first classified the samples into the following three subgroups: (i) MSI-stable phenotype represents same MSI levels between the tumor and corresponding normal tissue; (ii) MSI-low phenotype stands for the presence of <30% unstable microsatellite markers in the tumor compared to the adjacent normal tissue; and (iii) MSI-high phenotype is defined by the presence of !30% unstable microsatellite markers in the tumor sample compared to the adjacent normal tissue. Through combined analysis of the gene expression profile and MSI data, we applied a novel computational method based on machine learning and screened the gene panel specific for the different colorectal cancer subtypes. The obtained gene panel may be the optimal standards to further classify the various molecular subtypes of colorectal cancer with different MSI statuses. Our study will lay the foundation to further establish the various mechanisms of the different colorectal cancer subtypes with distinct MSI status.
Material and Methods

Dataset
We downloaded the MSI status of 147 TCGA (The Cancer Genome Atlas) colon adenocarcinoma and rectum adenocarcinoma (COAD/READ) patients from 16 and the gene expression of 270 COAD/READ patients from. 17 A total of 145 samples with both MSI and gene expression data were obtained, of which 95 were MSI-stable, 23 were MSI-low, and 27 were MSI-high samples. We constructed a 2-layer model to compare the gene expression differences among the MSI groups.
In the first layer, we compared 95 MSI-stable with the other 50 MSI-instable samples. These samples consisted the dataset D MSI1 . In the second layer, we further investigated the gene expression differences between the 23 MSI-low and 27 MSI-high samples, and these samples consisted the dataset What's new? Microsatellite instability (MSI), a key genetic mechanism implicated in colorectal cancer (CRC), is linked to drug reactivity and sensitivity in CRC patients and is useful for CRC subtype classification. Yet, little is known about the identity of MSIassociated genes or their role in CRC. Here, combined analysis of datasets on gene-expression profile and MSI status enabled the investigation of a number of differentially expressed genes from CRC samples. Genes optimal for the classification of CRC subtypes with different MSI statuses were identified. The gene panel could facilitate the discovery of biomarkers specific for CRCs with known MSI status. D MSI2 . For the gene expression data of the 145 samples, the 17,732 genes with reads per kilobase per million mapped reads (RPKM) with zero value in <50% of the samples were kept and log 2 transformed. If the original RPKM value was zero, the RPKM was replaced with the minimum non-zero value in the dataset to allow log 2 transformation. 18 
Feature selection
The 17,732 genes were extensively ranked to facilitate the identification of the essential genes that might be important biomarkers to distinguish the MSI samples. In our study, we applied a two-step feature selection method, including mRMR and incremental feature selection (IFS), to rank all gene expression features.
mRMR method. The mRMR method 19 is a mutual information (MI)-based feature selection method. Because this method considers the relevance between features and targets as well as redundancies between features, it is quite suitable for extracting important features from a complicated system and constructing an optimal feature subspace for classification. To date, it has been applied in complex biological and medical problems. [20] [21] [22] Correlations between two variables are evaluated using the following MI equation:
Iðx; yÞ5 ð ð pðx; yÞlog pðx; yÞ pðxÞpðyÞ dxdy
where p(x, y) is their joint probabilistic density, p(x) and p(y) are their marginal probabilistic densities. According to the definition, two variables with strong correlation would receive a large MI value. Mutual information has been proven to be better than correlation coefficient. 23 Two criteria were adopted in mRMR method: (i) Max-Relevance between features and targets and (ii) Min-Redundancy between features themselves. Therefore, each feature was evaluated according to its relevance to target variables and mean redundancies to other features. By applying the two criteria, the mRMR method can produce two feature lists, named MaxRel feature list and mRMR feature list, in which all features are ranked in a rigorous way. For example, in MaxRel feature list, features are ranked only according to the Max-Relevance criterion, that is, features are ranked in this list by descending order of their MI values to targets.
Given a dataset with N features, let X be a set containing N features, X s be a set with selected features, and X t be a set consisting of the rest features after selection, that is, X t 5X2X s . At the beginning, X s is set to be an empty set, and all N features are put into X t . Then, an iteration process is performed to remove features one by one from X t to X s . For each feature f in X t , its relevance to target variable c is calculated and denoted as D5Iðf ; cÞ, and the mean redundancies to features in X s are represented as R51=jX s j X f 0 2X s Iðf ; f 0 Þ. Both criteria are considered when the mRMR feature list is produced, and D-R is further calculated for each feature in X t . The feature with maximum D-R value is moved from X t to X s . When all features are put into X s , the iteration process stops. Accordingly, the mRMR feature list can be ranked according to the selection orders of features. That is, the first selected feature occupies the first place, followed by the second selected feature, and so on. The mRMR feature list can be formulated as follows:
Since the mRMR method considers the relationship within features and minimizes redundancies between features, the features selected by mRMR method will be compact, in other word, less features are needed to achieve great classification performance. IFS method. Only the ranks in mRMR list are not sufficient to identify a group of optimal features. Thus, the IFS method was further applied on the mRMR feature list in Section entitled "mRMR method". The combination of some features with high ranks provides good distinction of the different samples. In our study, each sample was represented by 17,732 features, implying we can construct 17,732 feature subsets if features were added one by one. Due to our limited computational power, we first constructed a series of feature subsets with big step, formulated as S
, that is, the ith subsets contained the first i 3 k features in mRMR feature list. Based on these feature subsets, a classification algorithm was built on each feature subset. The best prediction performance is obtained in a feature interval [min, max] by testing all feature subsets. Then, another series of feature subsets with Step 1 denoted as S 2 min , S 2 min11 ,. . .,S 2 max were constructed to extract the optimal features in this interval. Similar to the aforementioned procedure, a feature subset with optimal performance can be identified, and features in this subset are regarded as the optimal features. These optimum features are hypothesized to capture the key gene differences between MSI samples. We obtained an optimal classifier built on the optimal features.
Classification algorithm
A machine learning algorithm is necessary to build classifiers on feature subsets derived from the mRMR feature list and IFS method to classify the MSI samples. In our study, we used the popular support vector machine (SVM) as the prediction engine.
SVM is a supervised machine learning method based on statistical learning theory, which has been widely applied to solve classification and regression problem. 24 As first proposed by Vapik and Cortes in 1995, 25 SVM improves the generalization power of models using a limited number of samples by searching for the minimum structural risks and optimizing the trade-off between complexity and learning ability. This approach significantly facilitates the solution of problems associated with small-scale samples, nonlinear data, and multiclass pattern recognition. Many optimization algorithms can be used to build SVM classifiers. Here, sequential minimal optimization algorithm (SMO) 26 was used because of its high efficiency. SMO sequentially splits the problem into a series of sub-problems and then solves the sub-problems one by one. The algorithm named SMO in Weka, 27 which is a suite of software containing several stateof-the-art algorithms, was used to train the SVM classifier with its default parameters. In detail, the polynomial function was set as the kernel and the tolerance parameter was set to 0.001.
Evaluation measurements
In Sections entitled "Feature selection" and "Classification algorithm", we constructed SVM classifiers on different feature subsets. To evaluate their prediction performances, a 10-fold cross validation was performed on each classifier. This validation has been adopted in many applications because of its stable prediction results. As a binary classification problem, the following four measurements, namely, sensitivity (SN), specificity (SP), accuracy (ACC), and Matthew's correlation coefficient (MCC) were used to evaluate different aspects of prediction ability. These measurements were determined as follows:
where TP/TN is the number of correctly predicted positive/ negative samples, and FN/FP is the number of incorrectly predicted positive/negative samples. According to the definition, SN/SP represents the ratio of positive/negative samples, and ACC is the ratio of the total correctly predicted positive and negative samples. As a comprehensive measurement ranging from 21 to 1, MCC evaluates the error rate on two types of samples by considering the sample ratio in the dataset. Thus, MCC was selected as the primary measurement to evaluate the prediction ability of the classifiers, and others were provided as references.
Results
In our study, we proposed a two-layer method to identify CRC samples with different MSI status. Gene expression data were used to encode samples in the two constructed datasets, D MSI1 and D MSI2 . Then, a two-stage feature selection method and SVM were applied to search for the optimal features and classify samples in the two datasets, respectively.
For D MSI1 , we investigated the gene expression differences in the MSI samples with stable and instable statuses. The mRMR method was applied to the dataset D MSI1 , yielding a mRMR feature list, which is provided in Supporting Information Material S1. According to this feature list, a series of feature subsets as described in Section entitled "IFS method" were constructed, in which k was set to 10. Thus, the ith feature subset contained the top 10 3 i features in the mRMR feature list. After testing all feature subsets, the best prediction performance measured by MCC value was 0.721 when the first 1,790 features were used (see Supporting Information Material S2). Given that the feature subsets that contained the number of features ranging from 1,790 to 2,500 almost received the same MCC values, a large feature interval 1,700 to 2600 was temporarily obtained. A second series of feature subsets were also constructed based on the interval (1,700, 2,600). As introduced in Section entitled "IFS method", each feature subset in this series had one more feature than the former one. Similarly, by testing all feature subsets, the optimal MCC value of 0.721 was obtained when the top 1,788 features were used to construct the classifier. Finally, we obtained optimal features and a classifier to discriminate the stable from the unstable MSI samples. To facilitate observation, the trends for MCC values versus the corresponding number of features participating in building classifiers are illustrated as the IFS-curve in Figure 1 . In Figure  1a , boundaries of the feature interval are labeled with red makers. In addition, we magnified the x-value of the IFS-curve between 1,700 and 2,600 (Fig. 1b) , in which the optimal MCC value is marked with a red diamond. SNs, SPs, ACCs, and MCCs for classifiers trained on D MSI1 are listed in Supporting Information Material S2.
The mRMR method was again performed to samples in D MSI2 , yielding a mRMR feature list, which is provided as Supporting Information Material S3. Based on this feature list, feature subsets with parameter k 5 10 were again constructed to yield optimal features for classifying MSI-high and MSI-low samples. The obtained measurements mentioned in Section entitled "Evaluation measurements" are available in Supporting Information Material S4. For easy observation, we also plotted an IFS-curve using MCC as its y-axis and number of features as its x-axis, which is shown in Figure 2a . It can be observed that when the first 40 features were used to construct the classifier, the MCC value reached 1.000, which indicates the correct prediction of all samples. To further determine whether the perfect MCC value can be achieved using feature subsets containing less features, we tested the feature sets containing 31-39 features. The obtained SNs, SPs, ACCs, and MCCs are also listed in Supporting Information Material S4. Similarly, an IFS-curve with xvalue between 30 and 40 is illustrated in Figure 2b , in which the optimal MCC value is also labeled. It can be seen that the feature subset consisting of the top 36 features in the mRMR feature list can also yield a perfect MCC value of 1.000. Therefore, the top 36 features were denoted as optimal features. The optimal prediction performance and number of optimal features for datasets D MSI1 and D MSI2 are listed in Table 1 .
Discussion
In our study, we inferred for the first time the optimal genes to classify colorectal cancer samples with different MSI statuses. All obtained genes have been validated by recent publications, indicating the efficacy and accuracy of our prediction. The optimal features developed here encompass 1,788 features to identify stable and instable MSI samples in the dataset D MSI1 . However, we just documented several representative features because of the limitation in space. Based on the results in Figure 1a and Supporting Information Material S2, we selected and further documented the first 10 representative features in the mRMR feature list of D MSI1 , as shown in Table 2 . We hypothesize that the 10 features could provide sufficient characteristic information to identify the MSI status of the clinical samples. In addition, we analyzed similarly the top 10 features obtained from dataset D MSI2.
Genes contributing to the distinction of MSI-stable and MSI-instable
We first categorized all colorectal cancer cases into two major subgroups, namely, microsatellite stable and instable cases.
These subgroups have different microsatellite levels between tumor and the corresponding adjacent normal tissue. All top 10 predicted genes exhibited distinctive expression profiles between the two subgroups of colorectal cancer cases.
Substrate synthesis regulation. The top gene TRIM7 is a member of the tripartite motif family and functions in the initiation of glycogen synthesis. 28 A genome-wide analysis that focused on mucinous colorectal adenocarcinoma 29 confirmed that TRIM7 may be an optimal indicator for identifying colorectal adenocarcinoma subtypes. TRIM7 has also been validated to be a potential distinctive marker to identify cancer subtypes with instable microsatellite. 30 These findings indicate the efficacy and accuracy of TRIM7 as a characteristic biomarker in discriminating MSI colorectal cancer subtypes. MOCS3 encodes an intracellular protein responsible for the adenylation and activation of molybdopterinsynthase, 31 which have thiosulfate sulfurtransferase activity 32 . Thiosulfate sulfurtransferase may lead to different expression profiles in diverse colorectal cancer subtypes categorized by the stability of a microsatellite. This characteristic implies the potential relationship between MOCS3 and MSI. Apart from such two functional substrate synthesis regulatory genes, TPO which is also in our optimal prediction gene list encodes a membrane-bound glycoprotein and contributes to the synthesis of thyroid gland bioactive substances. 33, 34 Though not reported exactly in colorectal cancer, such gene has been reported to contribute to the pathogenesis of MSI by interfering DNA mismatch repair in multiple tumor subtypes like breast cancer, 35 implying such predicted gene may also be a functional gene associated with tumor driving MSI.
DNA mismatch repair (MMR). The third gene MLH1 is a key component of DNA MMR system. 36, 37 As mentioned above, MSI as a hyper mutable phenotype results from the loss of DNA MMR activity and is significantly implicated in colorectal cancer. 38 Approximately 91% of MSI-high cases exhibited functional abnormality of MLH1 gene at different levels, 39 indicating the effect of MLH1 for the identification of MSI colorectal cancer cases. Many previous studies also indicated the strong relationship between epigenetic regulation of MLH1 and DNA mismatch repair activity in multiple cancer subtypes, including colorectal cancer. 40, 41 Furthermore, recent publications confirmed that PD-1 inhibitors have different therapeutic effects on patients with different MSI status, 40, 41 indicating that PD-1 associated biological processes may also functionally relate to MSI. The gene MLH1 has also been confirmed to be functionally related to PD-1 associated MSI, implying the potential relationship between some identified genes and PD-1/PD-1L associated biological processes. 42 As we have mentioned above, the potential biological relationships between MSI and PD-1/PD-1L pathways may partially reflect the pathogenic mechanisms of MSI. In our predicted gene list, only MLH1 has been reported to be directly functionally related to such pathway indicating that on one hand, immune checkpoint abnormality may be one of the major pathogenic mechanisms of MSI, on the other hand, the potential pathogenic mechanisms of MSI may still be complicated since most of our predicted genes are not confirmed to be functionally related to such pathways remaining for further studies. DOCK8, which encodes a potential guanine nucleotide exchange factor, participates in a series of immunological process, such as NK cell cytotoxicity. 43 NK cells can filter and eliminate high MIS colorectal cancer cells, 44 and the cytotoxicity of NK cells is regulated by DOCK8. This result also suggests that DOCK8 may be involved in the regulation of MSI. FDXACB1, which encodes a protein containing ferredoxin-fold anticodon-binding domain, has also been predicted to be a potential indicator to distinguish microsatellite stable/instable colorectal cancer subtypes. Two studies have shown that FDXACB1 presented different expression profiles in colorectal cancer cases with diverse microsatellite statuses, 45 and this result is consistent with our prediction. However, the underlying mechanism of FDXACB1 leading to MSI remains unknown. Some reviews 46, 47 speculated that such gene may contribute to the MSI by interfering MMR and functionally involving with the PD-1/PD-1L pathways, validating our prediction.
Cell proliferation and differentiation. FGF19 plays a pivotal role in the regulation of embryonic development, cell proliferation, cell differentiation, and cell migration in normal and tumor tissues. 48 This gene has been reported to be involved in the immune regulation and escape processes of metastatic tumor cells with MSI, 49 implying the potential relationship between FGF19 and colorectal cancer with MSI. Although no direct evidence has been found to prove that FGF19 results in MSI, FGF19 may interact with DFNB63, and this process can induce specific MIS characteristics.
50
SMAD4 may result in chromosomal instability and then induce divergence of MSI in colorectal cancer. 51 This phenomenon indicates that SMAD4 may be an effective biomarker for the early warning of MSI during the initiation and progression of colorectal cancer. In colorectal cancer, the loss of SMAD4 prompts the accumulation of mutations in the microsatellite regions and then leads to the formation of MSI. 52 Transcription regulation. The following two predicted genes turn out to encode zinc finger proteins ZC4H2 and ZCCHC2. Zinc finger proteins have been widely reported to be abnormally functioning in colorectal cancer patients. 53, 54 As for its contribution to microsatellite instability, recent publications confirmed that such genes may involve in the regulation and maintenance of normal microsatellite status and patients with different MSI status may have different drug reactivity against zinc finger protein targeted drugs, 55, 56 implying the potential relationship between zinc finger proteins and colorectal cancer MSI status.
Genes contributing to the distinction of MSI-high and MSI-low
In addition to the predicted genes for distinguishing the MSI-stable and MSI-instable colorectal samples, we investigated the expression features to further categorize the colorectal MSI instable samples into MSI-high and MSI-low subgroups. According to our computational methods, we also screened and determined 36 optimal genes in D MSI2 , and these genes are listed in Table 3 and further analyzed. Here, we detailly analyzed the top ten genes as below.
Intercellular signal transduction. C9orf71, also named TMEM252, was predicted to have differential expression profiles in colorectal cancer samples with high or low MSI. The neighboring SNPs and microsatellite of C9orf71 have specific instability of repeat number. High MSI tends to accompany the pathological processes of various diseases including tumor. 38 Therefore, the expression profile of C9orf71 may indicate the MSI status of its nearby genes and further imply the distinction of MSI-high or MSI-low samples in colorectal cancer. CXCL13, as a specific B lymphocyte chemoattractant, binds to BLR1/CXCR5 and then participates in the specific immune regulation. CXCR5 is involved in the biological processes associated with tumor immune escape in colorectal cancer. 57 Colorectal cancer with different microsatellite statuses (MSI-high or MSI-low) have diverse effects on the para-carcinoma tissues to remodel the various tumor immune microenvironments. 45 Therefore, as the potential regulatory factor for the tumor immunogenesis, CXCL13 may diverse different expression patterns and then present distinct effects of tumor initiation on colorectal cancer cases with different microsatellite statuses (MSI-high or MSIlow). 58 This characteristic supports the efficacy and accuracy of our prediction.
Transcription regulation.The following gene, DLX3, which contains a vertebrate homeobox, was identified by sequence similarity with Drosophila developmental gene. DLX3 plays a key role in the development of the ventral forebrain. 59 This gene was reported to be negatively associated with the formation and accumulation of microsatellite polymorphism in human beings. 60 With specific downregulation of DLX3, patients present an increased level of malignancy in HNSCC colorectal cancer subtypes. 61 Apart from unknown predicted transcript, LOC100134229, another predicted gene ZMYND8, encodes a receptor for activated C-kinase (RACK) protein. This gene participates in the negative regulation of tumor metastasis via KDM5D-mediated downregulation of several downstream functional genes. 62 In early 2002, ZMYND8 has been confirmed to regulate the microsatellite distribution in mismatch repair-deficient colorectal cancers. This characteristic implies the potential distinctive significance of ZMYND8. 63 Furthermore, ZMYND8 was reported in a clinical study that showed different expression patterns and mutational spectra in MSI-high, MSI-low, and MSIstable colorectal cancer cases. 64 This finding is consistent with our prediction.
Energy metabolism regulation. CYB5D1, which encodes a specific metal ion binding protein, 65 contributes to tumorigenesis including the initiation and progression of colorectal cancer. 66 A study on cattle evolution has indicated that CYB5D1 might be related to the epigenetic modification status including the high or low MSI levels. For the specific biological interactions of CYB5D1 with MSI levels, a study in 2015 showed that the expression of the predicted gene CYB5D1 might be related to the epigenetic modification status including the high or low MSI levels in cattle. 67 CYB5D1 may directly regulate the microsatellite levels in tumor cells, 67 which validated the efficacy and accuracy of our prediction. Similar to the genes mentioned above, ENPP3 has the same potential to distinguish MSI-high and -low colorectal cancer subgroups. ENPP3 regulates the hydrolysis of extracellular nucleotides. 68 Although no direct evidence has shown that ENPP3 may indicate the MSI level in colorectal cancer, the gene can lead to the deletion of certain microsatellite regions in ovarian cancer. 69 Limited by the space, we only screened the top seven genes that contribute to distinguish MSI-high and MSI-low cases. The other genes will not be further analyzed one by one, although many genes, such as CDRT4, 70 CXCL10, 71 and QPR (EPRS), 72, 73 have also been experimentally confirmed. Further, we also analyzed the potential functional associations between layer-1 (MS-stable and MS-instable) genes and layer-2 (MSI-high and MSI-low) genes. There are both functional overlaps and distribution differences between such two groups of genes. As analyzed above, transcription regulatory genes have been predicted and confirmed to have different microsatellite status, contributing to the distinction of both MS-stable and MS-instable layer and MSI-high and MSI-low layer, indicating the specific biological effects of transcription regulatory genes on MSI in colorectal cancer. However, there are also some different enrichment characteristics between these two layer genes. Genes distinguishing MS-stable and MS-instable are also enriched in functional biological processes, like DNA mismatch repair and cell proliferation, while genes of the other layer are specifically enriched in energy metabolism and intracellular signal transduction, reflecting the distinctive function clustering distribution of such predicted genes on two layers and the complicated regulatory mechanisms of microsatellite instability in colorectal cancer. 70 
Conclusions
Based on our proposed SVM-based computational method, we applied a two-level screening approach to identify functional genes that contribute to the distinction of MSI-stable and MSI-instable samples of colorectal cancer, as well as MSI-low and MSI-high samples. According to recent publications, all predicted genes in our study have been confirmed to contribute to colorectal cancer subtyping process based on MSI status. Thus, the efficacy and accuracy of our prediction are validated. Hence, the computational workflow we presented may not only contribute to the identification of specific markers for colorectal cancer with different MSI statuses, but also provide a new tool to reveal the potential contribution of microsatellites based on functional related genes. 
